Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant - Priority Announcement: Ethics

McGill University

$273,952.00

Animals, Humans, and the Continuity of Evidence: A Study of Clinical Translation

EF 2010-11

Résumé
In the last two decades, researchers have made enormous progress in understanding the causes of human disease. Yet many important discoveries have not yet had an impact on the practice of medicine. This grant aims to understand some of the reasons why therapies that show promise in animals never make it to the clinic. We believe one of the reasons is that animal studies are often not as well designed as they should be. This grant will look at a large group of animal and human studies to see whether this is the case. Our study will further allow us to see whether certain research practices might improve chances that a new drug will have a clinical impact, and whether patients benefit or are harmed by participating in first in human drug studies.
Programme
Operating Grant - Priority Announcement: Ethics
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
215509
Name
Kimmelman Jonathan
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Biomedical
Prcname2
Knowledge Mobilization Science
Projecttitle
Animals, Humans, and the Continuity of Evidence: A Study of Clinical Translation
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$273,952
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Ethics
Keyworddelim
Disease Models; Knowledge Translation; Medical Evidence; Pharmaceutical Development; Phase 1 Trials; Preclinical Research; Research Integrity; Systematic Reviews; Translational Research; Validity
Abstract
In the last two decades, researchers have made enormous progress in understanding the causes of human disease. Yet many important discoveries have not yet had an impact on the practice of medicine. This grant aims to understand some of the reasons why therapies that show promise in animals never make it to the clinic. We believe one of the reasons is that animal studies are often not as well designed as they should be. This grant will look at a large group of animal and human studies to see whether this is the case. Our study will further allow us to see whether certain research practices might improve chances that a new drug will have a clinical impact, and whether patients benefit or are harmed by participating in first in human drug studies.
Competitiondate
201009
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kimmelman, Jonathan; Fergusson, Dean A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $273,952~ $0~